1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | |
| brand | String | Sunosi |
| structure | File | |
| classes | List of String, delimiter: , | Norepinephrine-dopamine reuptake inhibitor (NDRI) • wake-promoting agent |
| mechanism | String | Selective dopamine and norepinephrine reuptake inhibitor (DAT and NET inhibition). Unlike amphetamine, does not significantly release monoamines, pure reuptake inhibition. |
| uses | String | Excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea (OSA) |
| starting_dose | String | Narcolepsy: 75 mg PO once daily upon awakening, titrate every 3 days. OSA: 37.5 mg PO once daily, titrate. |
| preparations | String | 75 mg, 150 mg tablets |
| fda_max | String | 150 mg/d |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | ~30-60 min |
| duration | String | ~9 hours |
| halflife | String | ~7.1 hours |
| bioavailability | String | ~95% |
| pregnancy | String | Limited data; pregnancy exposure registry available |
| legal | String | Rx, Schedule IV (US) |
